Literature DB >> 18426902

In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.

Gregory G Stone1, Dennis Girard, Steve Finegan, Joan Duignan, John Schafer, Meghan Maloney, Richard P Zaniewski, Steven J Brickner, Sarah K Wade, Phuong T Le, Michael D Huband.   

Abstract

We evaluated a novel truncated hygromycin A analog in which the furanose ring was replaced with a 2-fluoro-2-cyclopropylethyl substituent for its activity against multidrug resistant gram-positive bacteria and compared its activity to the activities of linezolid, quinupristin-dalfopristin, and vancomycin. CE-156811 demonstrated robust in vitro activity against gram-positive bacteria that was comparable to that of linezolid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426902      PMCID: PMC2443909          DOI: 10.1128/AAC.01326-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Staphylococcus aureus cell extract transcription-translation assay: firefly luciferase reporter system for evaluating protein translation inhibitors.

Authors:  R W Murray; E P Melchior; J C Hagadorn; K R Marotti
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Hygromycin. II. Isolation and properties.

Authors:  R L MANN; R M GALE; F R VAN ABEELE
Journal:  Antibiot Chemother (Northfield)       Date:  1953-12

3.  Hygromycin. I. Preliminary studies on the production and biologic activity of a new antibiotic.

Authors:  R C PITTENGER; R N WOLFE; M M HOEHN; P N MARKS; W A DAILY; J M McGUIRE
Journal:  Antibiot Chemother (Northfield)       Date:  1953-12

Review 4.  Antibacterial resistance worldwide: causes, challenges and responses.

Authors:  Stuart B Levy; Bonnie Marshall
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

5.  Lack of development of new antimicrobial drugs: a potential serious threat to public health.

Authors:  S Ragnar Norrby; Carl Erik Nord; Roger Finch
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

6.  Hygromycin A, a novel inhibitor of ribosomal peptidyltransferase.

Authors:  M D Guerrero; J Modolell
Journal:  Eur J Biochem       Date:  1980-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.